116 related articles for article (PubMed ID: 14666651)
1. Colorectal cancer screening in asymptomatic adults: the role of FDG PET scan.
Chen YK; Kao CH; Liao AC; Shen YY; Su CT
Anticancer Res; 2003; 23(5b):4357-61. PubMed ID: 14666651
[TBL] [Abstract][Full Text] [Related]
2. Application of PET and PEt/CT imaging for cancer screening.
Chen YK; Ding HJ; Su CT; Shen YY; Chen LK; Liao AC; Hung TZ; Hu FL; Kao CH
Anticancer Res; 2004; 24(6):4103-8. PubMed ID: 15736459
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of ¹⁸F-FDG PET/CT for detection of advanced colorectal adenoma.
Gollub MJ; Grewal RK; Panu N; Thipphavong S; Sohn M; Zheng J; Moskowitz CS
Clin Radiol; 2014 Jun; 69(6):611-8. PubMed ID: 24581969
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects.
Chen YK; Ding HJ; Chen KT; Chen YL; Liao AC; Shen YY; Su CT; Kao CH
Anticancer Res; 2005; 25(2B):1421-6. PubMed ID: 15865100
[TBL] [Abstract][Full Text] [Related]
5. Incidental focal uptake in colorectal location on oncologic ¹⁸FDG PET and PET/CT studies: histopathological findings and clinical significances.
Fuertes J; Montagut C; Bullich S; Coma MI; Mestre-Fusco A; Suárez-Piñera M; Trampal C; Bellmunt J
Rev Esp Med Nucl Imagen Mol; 2015; 34(2):95-101. PubMed ID: 25263718
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography: a preliminary report.
Terauchi T; Murano T; Daisaki H; Kanou D; Shoda H; Kakinuma R; Hamashima C; Moriyama N; Kakizoe T
Ann Nucl Med; 2008 Jun; 22(5):379-85. PubMed ID: 18600415
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of 2-[
Sekiguchi M; Kakugawa Y; Terauchi T; Matsumoto M; Saito H; Muramatsu Y; Saito Y; Matsuda T
J Gastroenterol; 2016 Dec; 51(12):1122-1132. PubMed ID: 27021493
[TBL] [Abstract][Full Text] [Related]
8. Detection of colorectal cancer and adenomas by FDG-PET cancer screening program: results based on a nationwide Japanese survey.
Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
Ann Nucl Med; 2014 Apr; 28(3):212-9. PubMed ID: 24347363
[TBL] [Abstract][Full Text] [Related]
9. Incidental colonic focal lesions detected by FDG PET/CT.
Gutman F; Alberini JL; Wartski M; Vilain D; Le Stanc E; Sarandi F; Corone C; Tainturier C; Pecking AP
AJR Am J Roentgenol; 2005 Aug; 185(2):495-500. PubMed ID: 16037527
[TBL] [Abstract][Full Text] [Related]
10. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
11. FDG uptake in colonic villous adenomas.
Arslan N; Dehdashti F; Siegel BA
Ann Nucl Med; 2005 Jun; 19(4):331-4. PubMed ID: 16097645
[TBL] [Abstract][Full Text] [Related]
12. The potential usefulness of (18)F-FDG PET/CT for detecting colorectal carcinoma and adenoma in asymptomatic adults.
Hwang JP; Woo SK; Yoon SY; Jeong SY
Ann Nucl Med; 2015 Feb; 29(2):157-63. PubMed ID: 25358843
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings.
Drenth JP; Nagengast FM; Oyen WJ
Eur J Nucl Med; 2001 Dec; 28(12):1766-9. PubMed ID: 11734913
[TBL] [Abstract][Full Text] [Related]
14. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
15. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer.
Yi JG; Marom EM; Munden RF; Truong MT; Macapinlac HA; Gladish GW; Sabloff BS; Podoloff DA
Radiology; 2005 Jul; 236(1):271-5. PubMed ID: 15987980
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of benign vs malignant hepatic lesions with positron emission tomography.
Delbeke D; Martin WH; Sandler MP; Chapman WC; Wright JK; Pinson CW
Arch Surg; 1998 May; 133(5):510-5; discussion 515-6. PubMed ID: 9605913
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
[TBL] [Abstract][Full Text] [Related]
18. 2-(18F)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study.
van Kouwen MC; Nagengast FM; Jansen JB; Oyen WJ; Drenth JP
J Clin Oncol; 2005 Jun; 23(16):3713-7. PubMed ID: 15923568
[TBL] [Abstract][Full Text] [Related]
19. Classification of Physiological 18F-fluorodeoxyglucose Uptake in the Large Intestine: a Preliminary Study.
Yasuda S; Kobayashi K; Ono M; Miyatake Y; Miyauchi M; Kato T; Tanaka T; Ito M; Yamamoto N
Tokai J Exp Clin Med; 2014 Sep; 39(3):141-5. PubMed ID: 25248430
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography for the detection of colorectal adenomas.
Ravizza D; Bartolomei M; Santoro L; Tamayo D; Fiori G; Trovato C; De Cicco C; De Roberto G; Paganelli G; Crosta C
Dig Liver Dis; 2010 Mar; 42(3):185-90. PubMed ID: 19643688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
